Irbegen

Irbesartan, the active ingredient in Irbegen, is an Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It treats hypertension and helps protect kidney function in patients with diabetic nephropathy.

GNH USA supplies Irbegen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Irbesartan is an ARB that targets the renin‑angiotensin system to manage cardiovascular and renal conditions.

- Hypertension: lowers blood pressure and reduces the risk of cardiovascular events. - Diabetic nephropathy: slows the progression of kidney damage in patients with type 2 diabetes.

Adverse reactions may occur with any medication and should be monitored by a healthcare professional.

Common Side Effects: - Dizziness: feeling light‑headed, especially after standing. - Headache: mild to moderate intensity. - Fatigue: unusual tiredness without exertion. - Diarrhea: loose stools occurring intermittently.

Serious or Rare Side Effects: - Angioedema: swelling of the face, lips, tongue, or throat that may impair breathing. - Hyperkalemia: elevated blood potassium levels that can affect heart rhythm.

Before starting Irbegen, certain precautions are recommended. - Blood pressure monitoring: check regularly to ensure therapeutic effect. - Renal function assessment: evaluate serum creatinine and eGFR. - Serum potassium: monitor for hyperkalemia, especially with potassium‑sparing agents. - Hepatic impairment: use with caution in patients with severe liver disease. - Elderly patients: start at lower doses and titrate slowly. - Store at below 25°C: keep in the original container, protect from moisture and direct light.

Irbesartan may interact with other medicines; some combinations require avoidance while others need close monitoring.

Major Interactions (Avoid): - Aliskiren (in diabetic patients): increased risk of renal impairment and hyperkalemia. - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia. - ACE inhibitors: concurrent use can lead to excessive potassium rise and renal dysfunction.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive effect and affect renal function. - Lithium: can raise lithium concentrations, increasing toxicity risk.